Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques F Meis

Showing results (181-190 of 430) with videos related to

Pageof 43
Sort By:
Medical Mycology|June 28, 2014
Roussoella percutanea, a novel opportunistic pathogen causing subcutaneous mycosesSarah A Ahmed, David A Stevens, Wendy W J van de Sande, et al.
Antimicrobial Agents and Chemotherapy|March 11, 2015
Pharmacodynamics of isavuconazole in an Aspergillus fumigatus mouse infection modelSeyedmojtaba Seyedmousavi, Roger J M Brüggemann, Jacques F Meis, et al.
Mycoses|May 13, 2022
Global prevalence and subgroup analyses of coronavirus disease (COVID-19) associated Candida auris infections (CACa): A systematic review and meta-analysisNarges Vaseghi, Joobin Sharifisooraki, Hossein Khodadadi, et al.
Mycoses|October 25, 2017
Use of cell surface protein typing for genotyping of azole-resistant and -susceptible Aspergillus fumigatus isolates in IranMahsa Falahatinejad, Afsane Vaezi, Hamed Fakhim, et al.
The Journal of Antimicrobial Chemotherapy|December 25, 2014
Specific antifungal susceptibility profiles of opportunists in the Fusarium fujikuroi complexAbdullah M S Al-Hatmi, Anne D van Diepeningen, Ilse Curfs-Breuker, et al.
Journal of Clinical Microbiology|July 3, 2025
Evaluation of the MIC test strips for antifungal susceptibility testing of <i>Candidozyma auris</i> (<i>Candida auris</i>) using a representative international collection of isolatesMaria Siopi, Sevasti Leventaki, Ioannis Pachoulis, et al.
The Journal of Antimicrobial Chemotherapy|December 26, 2015
In vitro combinations of natamycin with voriconazole, itraconazole and micafungin against clinical Fusarium strains causing keratitisAbdullah M S Al-Hatmi, Joseph Meletiadis, Ilse Curfs-Breuker, et al.
Antibiotics (Basel, Switzerland)|September 29, 2020
A Cluster of <i>Candida auris</i> Blood Stream Infections in a Tertiary Care Hospital in Oman from 2016 to 2019Jalila Mohsin, Sanjeewani Weerakoon, Sarah Ahmed, et al.
Antimicrobial Agents and Chemotherapy|August 31, 2016
Potent Activities of Novel Imidazoles Lanoconazole and Luliconazole against a Collection of Azole-Resistant and -Susceptible Aspergillus fumigatus StrainsMahdi Abastabar, Nooshin Rahimi, Jacques F Meis, et al.
Antimicrobial Agents and Chemotherapy|March 20, 2013
Molecular characterization and in vitro antifungal susceptibility profile of Schizophyllum commune, an emerging basidiomycete in bronchopulmonary mycosesAnuradha Chowdhary, Shallu Kathuria, Pradeep Kumar Singh, et al.
Pageof 43

Showing results (181-190 of 430) with videos related to

Sort By:
Pageof 43
Medical Mycology|June 28, 2014
Roussoella percutanea, a novel opportunistic pathogen causing subcutaneous mycosesSarah A Ahmed, David A Stevens, Wendy W J van de Sande, et al.
Antimicrobial Agents and Chemotherapy|March 11, 2015
Pharmacodynamics of isavuconazole in an Aspergillus fumigatus mouse infection modelSeyedmojtaba Seyedmousavi, Roger J M Brüggemann, Jacques F Meis, et al.
Mycoses|May 13, 2022
Global prevalence and subgroup analyses of coronavirus disease (COVID-19) associated Candida auris infections (CACa): A systematic review and meta-analysisNarges Vaseghi, Joobin Sharifisooraki, Hossein Khodadadi, et al.
Mycoses|October 25, 2017
Use of cell surface protein typing for genotyping of azole-resistant and -susceptible Aspergillus fumigatus isolates in IranMahsa Falahatinejad, Afsane Vaezi, Hamed Fakhim, et al.
The Journal of Antimicrobial Chemotherapy|December 25, 2014
Specific antifungal susceptibility profiles of opportunists in the Fusarium fujikuroi complexAbdullah M S Al-Hatmi, Anne D van Diepeningen, Ilse Curfs-Breuker, et al.
Journal of Clinical Microbiology|July 3, 2025
Evaluation of the MIC test strips for antifungal susceptibility testing of <i>Candidozyma auris</i> (<i>Candida auris</i>) using a representative international collection of isolatesMaria Siopi, Sevasti Leventaki, Ioannis Pachoulis, et al.
The Journal of Antimicrobial Chemotherapy|December 26, 2015
In vitro combinations of natamycin with voriconazole, itraconazole and micafungin against clinical Fusarium strains causing keratitisAbdullah M S Al-Hatmi, Joseph Meletiadis, Ilse Curfs-Breuker, et al.
Antibiotics (Basel, Switzerland)|September 29, 2020
A Cluster of <i>Candida auris</i> Blood Stream Infections in a Tertiary Care Hospital in Oman from 2016 to 2019Jalila Mohsin, Sanjeewani Weerakoon, Sarah Ahmed, et al.
Antimicrobial Agents and Chemotherapy|August 31, 2016
Potent Activities of Novel Imidazoles Lanoconazole and Luliconazole against a Collection of Azole-Resistant and -Susceptible Aspergillus fumigatus StrainsMahdi Abastabar, Nooshin Rahimi, Jacques F Meis, et al.
Antimicrobial Agents and Chemotherapy|March 20, 2013
Molecular characterization and in vitro antifungal susceptibility profile of Schizophyllum commune, an emerging basidiomycete in bronchopulmonary mycosesAnuradha Chowdhary, Shallu Kathuria, Pradeep Kumar Singh, et al.
Pageof 43